Hospital de Clínicas Dr. Manuel Quintela Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01750749
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Hospital de Clínicas Dr. Manuel Quintela

Active Ingredients

Drugs in Phase 4 Trials (3)

diosmetine (1 trial)

hesperidin (1 trial)

ibuprofen (motrin) (1 trial)

Drugs in Phase 3 Trials (1)

levocarnitine (carnitor) (1 trial)

Drugs in Phase 1 Trials (1)

allogeneic adipose derived mesenchymal stem cell (1 trial)

Drugs in Other Trials (2)

lactulose (cephulac) (1 trial)

polyethylene glycol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leg Ulcer (Phase 1)

Syndrome (Phase 4)

Ulcer (Phase 1)

Varicose Ulcer (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7